Comparison of the anti-neoplastic effects of dirhodium(II) tetrapropionate and its adducts with nicotinate and isonicotinate anions in mice bearing Ehrlich tumors-Reference-Cited by-同舟云学术

Comparison of the anti-neoplastic effects of dirhodium(II) tetrapropionate and its adducts with nicotinate and isonicotinate anions in mice bearing Ehrlich tumors

Published:2006-10 Issue:10 Volume:41 Page:1214-1216
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

de Souza Aparecido Ribeiro,Coelho Eliel Pereira,Zyngier Szulim Ber

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference15 articles.

1. New metal complexes as potential therapeutics;Zhang;Curr. Opin. Chem. Biol.,2003

2. Studies of rhodium(II) carboxylates as potential antitumor agents;Erck;Proc. Soc. Exp. Bio. Med.,1974

3. Precious metals 1985;Bear,1986

4. Rh2(CF3CONH)4: the first biological assays of a rhodium(II) amidate;Esposito;Met. Based Drugs,1997

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self‐Supported Heterogeneous Dirhodium(II) Catalyst for Nitrene and Carbene Transfer Reactions;European Journal of Organic Chemistry;2024-01-29

2. Experimental orthotopic breast cancer as a model for investigation of mechanisms in malignancy and metastasis to the lymph nodes;International Journal of Veterinary Science and Research;2019-07-16

3. Development of a Promising Antitumor Compound Based on Rhodium(II) Succinate Associated with Iron Oxide Nanoparticles Coated with Lauric Acid/Albumin Hybrid: Synthesis, Colloidal Stability and Cytotoxic Effect in Breast Carcinoma Cells;Journal of Nanoscience and Nanotechnology;2018-06-01

4. Tribenzyltin carboxylates as anticancer drug candidates: Effect on the cytotoxicity, motility and invasiveness of breast cancer cell lines;European Journal of Medicinal Chemistry;2017-01

5. Bio-distribution and Toxicity of Noble Metal Nanoparticles in Humans;Metal Nanoparticles in Pharma;2017